Michal Ayalon

No open positions remaining

59 year

Health Technology

Consumer Services

Profile

Michal Ayalon worked as Vice President of Research and Development at Kamada Ltd. from 2019 to 2022.
Prior to that, she held the same position at Galmed Pharmaceuticals Ltd. in 2015-2016.
In 2018-2019, she was Head of Research and Development at 89Bio Ltd. Ayalon received her undergraduate, graduate, and doctorate degrees from Tel-Aviv University.

Former positions of Michal Ayalon

Companies	Position	End
KAMADA LTD.	Chief Tech/Sci/R&D Officer	28/02/2022
89Bio Ltd. 89Bio Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies and drugs for treatments of patients living with nonalcoholic steatohepatitis	Chief Tech/Sci/R&D Officer	01/01/2019
GALMED PHARMACEUTICALS LTD.	Chief Tech/Sci/R&D Officer	01/01/2016

See the detail of Michal Ayalon's experience

Training of Michal Ayalon

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michal Ayalon's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Tel-Aviv University Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kamada Ltd. Kamada Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and manufactures plasma-derived therapeutics products	Health Technology
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures aramchol for non-alcoholic steatohepatitis	Health Technology
89Bio Ltd. 89Bio Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies and drugs for treatments of patients living with nonalcoholic steatohepatitis	Health Technology